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ABSTRACT 
New insights into the phenotype of Joint Hypermobility Syndrome (JHS) and Ehlers-Danlos 
Syndrome-hypermobile type (hEDS) have raised many issues in relation to classification, 
diagnosis, assessment and treatment. Within the multidisciplinary team, physical therapy plays a 
central role in management of individuals with hypermobility related disorders. However, many 
physical therapists are not familiar with the diagnostic criteria, prevalence, common clinical 
presentation and management. This guideline aims to provide practitioners with the state of the art 
regarding the assessment and management of children, adolescents and adults with JHS/hEDS. 
Due to the complexity of the symptoms in the profile of JHS/hEDS, the International Classification 
of Functioning, Disability and Health (ICF) is adopted as a central framework whereby the umbrella 
term of disability is used to encompass functions, activities and participation, as well as 
environmental and personal factors. The current evidence-based literature regarding the 
management of JHS/hEDS is limited in size and quality and there is insufficient research exploring 
the clinical outcomes of a number of interventions. Multicenter randomized controlled trials are 
warranted to assess the clinical and cost-effectiveness of interventions for children and adults. 
Until further multicenter trials are conducted, clinical decision-making should be based on 
theoretical and the current limited research evidence. For all individuals diagnosed with JHS/hEDS, 
international consensus and combined efforts to identify risk profiles would create a better 
understanding of the pathological mechanisms and the potential for optimizing health care for 
affected individuals.  
 
Keywords  
Physical therapy, diagnostics, treatment, guidelines, Joint Hypermobility Syndrome / Hypermobile 
Ehlers Danlos syndrome , International Classification of Functioning 
INTRODUCTION 
In the last decade, scientific research in the area of hypermobility related disorders has grown. 
Scientific exploration has not only provided new insights into the phenotype of Joint Hypermobility 
Syndrome (JHS) and Ehlers-Danlos Syndrome-hypermobility type (hEDS), but it has also raised 
many issues in relation to classification, diagnosis, assessment and treatment. We will refer to 
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these overlapping/ indistinguishable clinical entities [Tinkle et al., 2009; Remvig et al, 2011], in this 
paper as JHS/hEDS. Within the multidisciplinary team, physical therapy plays a central role in 
management of individuals with hypermobility related disorders [Grahame 2008, Simmonds and 
Keer 2007; Scheper et al., 2013, 2016]. The reported prevalence of JHS/hEDS in adult physical 
therapy outpatient musculoskeletal settings has been reported to be between 30% [Connelly et al., 
2015] and 55% [Clark and Simmonds, 2011]. Despite the relatively high incidence of JHS/hEDS, 
recent research has found that many physical therapists and other clinicians are not familiar with 
the diagnostic criteria, prevalence or common clinical presentation of affected individuals [Billings 
et al., 2015; Lyell et al., 2016; Russek et al., 2016], whereas clinicians also experience a lack of 
awareness of this condition [Rombaut et al., 2015; Billings et al., 2015; Terry et al., 2015; Lyell et 
al., 2016]. This guideline aims to provide physical therapists and other clinicians with the state of 
the art regarding the assessment and management of children, adolescents and adults with 
JHS/hEDS. In preparing the guideline, the quality of evidence is graded according to the GRADE 
criteria (Grading of Recommendations Assessment, Development and Evaluation) [Balshem et al 
2011]. The paper has been written based on a synthesis of best evidence available and consensus 
opinion of an international group of researchers, clinicians and patient representatives. Evidenced 
based assessment and treatment strategies should be used where available. In the absence of 
these, therapists should be guided by clinical reasoning and assessment and treatment should be 
tailored to the individual patient’s needs. 
 
Due to the complexity of the symptoms in the profile of JHS/hEDS, the International Classification 
of Functioning, Disability and Health (ICF) is adopted as an overarching framework [Atkinson and 
Nixon-Cave, 2011). Disability, according to the World Health Organization, is an umbrella term 
covering functions, activities and participation, as well as environmental and personal factors 
(WHO, 2015). In children, adolescents and adults with JHS/hEDS, impairments in the ICF domain 
body and function may result in decreased functional capacity and restrictions in participation.   
The Beighton tests for assessing generalized joint hypermobility (GJH) are widely used and were 
described about 40 years ago, but only with photos and unclear legends accompanying [Beighton 
1973]. Considerable variation exists in the utilization of this tool, the cut-off level used for a positive 
test and in the criteria definition of GJH [Remvig et al., 2007]. The Beighton score, consisting of 
five clinical maneuvers, is scored dichotomously (0/1) from which a total score, ranging from 0 to 9, 
is calculated. It is a widespread belief that GJH is present in adults with a Beighton score of ≥4 as 
described in the diagnostic Brighton criteria [Grahame et al., 2000] and for hEDS ≥5 [Beighton et 
al., 1998]. Other cut-off points for detecting the presence of GJH have been proposed, especially 
for children, among others ≥6, ≥7, and ≥8 [Jansson et al., 2004]. Although these testing procedures 
and diagnostic criteria have been in place for years and are considered the gold standard from 
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infancy to old age [Adib et al., 2005], criticism has arisen from clinicians and researchers about its 
diagnostic and clinical usefulness and predictive validity [Juul-Kristensen et al., 2016]. Beyond the 
Beighton scale, other assessment measures should be utilized within each domain of the ICF and 
clinical reasoning should underpin where appropriate, and where possible evidence-based, tailored 
treatment strategy.  
 
JHS/hEDS IN CHILDHOOD 
Children with JHS/hEDS may experience multiple impairments as a result of increased laxity of the 
connective tissues, incorporating complaints in all domains of the ICF as illustrated in Figure 1 
[Pacey et al., 2014]. 
 
Pain and Health Related Quality of Life 
In JHS/hEDS pain is often present. It is not known why some children develop pain and other 
symptoms, while others do not. The primary hypothesis regarding the development of 
musculoskeletal complaints is localized biomechanical overload during activity, with a high risk of 
repetitive trauma. Generalized joint instability may cause the occurrence of micro-traumas in joint 
surfaces, leading towards adaptation and compensation of movement patterns, consequently 
causing overload in other areas of the musculoskeletal system [Ferrell et al., 2004]. Pain 
exacerbated by activity is a distinguishing feature of JHS/hEDS. Eighty-one percent of children with 
JHS attending a rheumatology service reported that their pain was exacerbated by exercise [Adib 
et al., 2005]. All of these children reported experiencing pain in the 24 hours following exercise: 
65% immediately post exercise, 59% later that evening and 50% the following morning. The knee, 
a weight-bearing joint of the lower limb, and the shoulder, are the most commonly affected sites of 
pain in children with JHS/hEDS [Adib et al., 2005; Pacey et al., 2015]. Parent and child self-
reported pain intensity is highly correlated [Pacey et al., 2015], although parents have been shown 
to underestimate their child’s perception of pain [Kemp et al., 2010]. Recently it was shown that 
children and adults diagnosed with JHS/hEDS are not only characterized by GJH, and chronic 
pain, but also by the presence of generalized hyperalgesia (GHA) [Scheper et al., 2016]. The 
presence of GHA may indicate involvement of the central nervous system in the development of 
chronic pain and may not only provide insights as to the phenotype of GJH related disorders, but 
also indicates diagnostic qualities that may be useful in clinical practice [Scheper et al., 2016]. 
  
Children aged 9-12 years old with JHS/hEDS and knee pain report lower Health Related Quality of 
Life (HRQL) than healthy children at the same age [El-Metwally et al., 2005; Fatoye et al., 2011]. 
Children with JHS/hEDS experience poor HRQL and disabling fatigue, with parent scores providing 
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a good proxy. Pain, fatigue and the presence of stress incontinence symptoms have been 
demonstrated to have the greatest impact on their HRQL [Pacey et al., 2015].  
 
Dysfunction in JHS/hEDS can be the result of chronic pain but also due to involvement of multiple 
systems, psychological distress and related disability. How chronic pain and systemic deficits come 
into effect and interact with each other is currently unknown. The specific problems related to the 
GJH related syndromes as compared with other chronic pain syndromes are still challenging for 
most clinicians and scientists due to many issues surrounding etiology, disease classification, 
diagnostics and treatment [Scheper et al., 2015]. 
 
Proprioception, Muscle Strength and Balance 
Another important factor within the biomechanical pathway in JHS/hEDS patients may be reduced 
proprioceptive acuity, which has been suggested to be important for the occurrence of gait 
abnormalities and musculoskeletal pain [Smith et al., 2013]. Decreased knee joint proprioception in 
combination with decreased knee flexor and extensor muscle strength has also been reported in 
children with JHS/hEDS [Fatoye et al., 2009]. This was partly confirmed in another study of 
adolescents and adults with JHS/hEDS where the reflex in the knee extensors was absent in 47% 
of 15 patients, compared with a healthy control group in which this reflex was present in all 
subjects [Ferrell et al., 2007]. Decreased muscle strength is associated with activity limitations in 
JHS/hEDS patients. Joint proprioception has been found to influence this association and should 
be considered in the development of new treatment strategies for patients with JHS/hEDS 
[Scheper et al., 2016]. Children between 8-16 years of age with JHS/hEDS assessed by the 
balance sub-section of the Bruininks-Oseretsky test of motor proficiency (2nd edition), have been 
found to have significantly reduced balance [Schubert-Hajlmarsson et al., 2012]. 
 
Joint Instability 
Dislocations or subluxations in more than one joint, or in one joint on more than one occasion, form 
part of the diagnostic criteria for JHS/hEDS. Consequently, recurrent joint instability episodes are 
commonly reported by children with JHS/hEDS, with the knee, ankle and shoulder as the most 
affected joints [Pacey et al., 2015]. 
 
Extra-articular Features   
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In children with JHS/hEDS involvement of not only the skin and joints but also other organ systems 
consisting of different types of collagen, e.g. bone and blood vessels, indicates a more systemic 
rather than local involvement. In children 8-9 years old with JHS/hEDS, lower ultrasound values in 
bone, higher degradation products in urine, higher skin extensibility and lower blood pressure have 
been observed in comparison with a non-symptomatic hypermobile group [Engelbert et al., 2003]. 
High levels of urinary incontinence are reported in children with JHS/hEDS [Pacey et al., 2015], 
where such systemic concerns cause significant discomfort and impacts significantly on function 
and quality of life, a referral to a pediatrician or system specialist is required [de Kort et al., 2003].  
 
A relationship between JHS/hEDS and a characteristic neurodevelopmental profile affecting 
coordination is emerging. Common symptoms shared between children with JHS/hEDS and those 
with developmental coordination disorder (DCD) have been highlighted [Kirby et al., 2007]. Multiple 
clinical features of JHS/hEDS, such as “double-jointedness”, joint pain, flat feet, easy bruising and 
dysautonomic symptoms, have been found to be significantly more frequent in children with DCD 
than in children without [Kirby et al., 2007]. Amongst children with JHS presenting to health care 
services, 36% report poor coordination and 48% report clumsiness, and problems with gait, falls 
and coordination are the second most common presenting complaint [Adib et al., 2005]. Overall 
gross motor abilities have been shown to be reduced in 22% of children (mean 8 years of age) with 
JHS/hEDS measured with the Movement Assessment Battery for Children [Hanewinkel et al., 
2009].  
 
Symptoms of gastrointestinal dysfunction (GID) and dysautonomia may commence very early in a 
child’s life. The most common GID symptoms include gastrointestinal reflux, abdominal pain and 
slow transit constipation or long standing intractable diarrhea; however, abnormalities from the 
mouth to the anus have been reported [Abonia et al., 2013]. 
 
Psychological Symptoms 
Children and adolescents with JHS/hEDS aged 8-15 years report significantly poorer emotional 
functioning on the Pediatric Quality of Life Inventory compared to their non-hypermobile peers 
[Pacey et al., 2015]. Furthermore, self-esteem, behavior and psychosocial functioning of children 
with JHS/hEDS have been shown to be significantly lower than population norms prior to 
commencing a treatment program [Pacey et al., 2013].  
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Activities: Motor development, gait pattern, physical fitness 
The medical history often reveals developmental delay during early childhood and DCD may 
coexist [(Kirby et al., 2005; Kirby and Davies, 2007)]. Congenital hypotonia or ‘floppy infant’ 
syndrome and joint hypermobility (JH) have been recognized by a number of researchers [Mintz-
Itkin et al., 2009]. Late walking and clumsiness are characteristics commonly reported by parents 
[Adib et al., 2005]. In JHS/hEDS, non-physiological gait-patterns (absolute comparisons: spatio-
temporal, kinematics and kinetics) have been demonstrated in children. These patterns were not 
consistent and a high variability within patients was present [Fatoye et al., 2011], and children with 
JHS/hEDS and multiple joint pain, had significantly decreased knee flexion in the swing phase, as 
well as increased knee extension in mid-stance during walking. Also, decreased lateral joint 
stability and different stabilization strategies (kinetic patterns) in children and adults with GJH have 
been shown [Falkerslev et al., 2013]. 
 
As far as the gait pattern of children with JHS/hEDS is concerned, it has been reported that 
‘hypermobile joints, reduced proprioception, weak muscles and reduced stamina (endurance) can 
profoundly affect the gait of a child with JHS/hEDS. To correct this, the causes of the abnormalities 
need to be identified and worked on separately, before the gait will improve’ [Murray 2006]. 
Problems with gait, falls and coordination are the second most common presenting complaint of 
children with JHS/hEDS presenting to an outpatient rheumatology clinic [Adib et al., 2005]. 
 
In children with JHS/hEDS, a relationship was found with exercise induced pain and reduced 
aerobic fitness and physical capacity fitness compared with a healthy reference group, measured 
as absolute and relative (related to body mass) peak VO2 [Engelbert et al., 2006], and also when 
assessed with a sub-maximal 6 minute walk test [Hanewinkel et al., 2009]. The reason for this poor 
aerobic fitness was assumed to be due to musculoskeletal pain, resulting in inactivity and 
deconditioning, which could then result in exercise-induced pain and intolerance. 
 
Participation: Hobbies, sport and social activities 
Children with GJH are less active in sports and miss education more often in comparison with their 
healthy peers with normal joint mobility [Jansson et al., 2004]. Qualitative research with children 
with JHS/hEDS and their parents has identified ‘difficulties at school’ as being one of the 6 main 
themes, when discussing symptoms prior to commencing a treatment program [Birt et al., 2014]. A 
retrospective chart audit also showed that 40% of affected children report handwriting difficulties, 
24% report ‘problems at school’, 41% report missing time from school, and 48% were unable to 
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participate in physical education classes as a result of their condition [Adib et al., 2005]. A recent 
study showed that children 8-16 years with JHS/hEDS had significantly decreased participation in 
housework, riding a bicycle, taking part in sport or outdoor games, as assessed by the Frequency 
of Participation Questionnaire, in conjunction with a higher frequency of participation in non-
sporting games and a higher need to rest [Schubert-Hajlmarsson et al., 2012]. Withdrawal from 
physical activity due to their condition has also been reported by children and their parents [Birt et 
al., 2014].  
 
It is essential therefore for clinicians to explore and understand the impact of the child’s problems 
on school, home and social life. Some children have poor school attendance records due to 
recurrent injury, pain and systemic issues. Many children reduce physical activity and stop 
participating in physical education due to fear of re-injury or pain.  
 
Finding out about hobbies, ambitions and sports that a child enjoys is very helpful in driving the 
management plan. Physical therapists and parents have difficulty when searching for sports and 
hobbies that suit the child, because many sports involve movement or activities with high risk of 
injuries in unstable joints. Contact sports for example has been suggested to be an injury risk 
factor for knee injuries amongst individuals with GJH [Pacey et al., 2010]. In reality, many children 
with JHS/hEDS cannot keep on participating in hobbies and activities they prefer, even though 
their hypermobility originally was an asset for this activity at first sight. It can be very challenging to 
find activities they like and which do not exacerbate their joint instability.  
 
JHS/EDS-HT IN ADULTHOOD  
 
Pain, Fatigue and Health Related Quality of Life 
Adults diagnosed with JHS/hEDS often experience joint pain in multiple joints, which can vary from 
localized to widespread pain, in nature and severity [Remvig et al., 2011; Connelly et al., 2015]. 
Chronic widespread pain is frequently present in patients with the JHS/hEDS. In half of the patient 
group, a predominantly neuropathic pain component was present [Rombaut et al., 2011]. This 
study provides evidence for the existence of hyperalgesia even in asymptomatic areas 
(generalized secondary hyperalgesia). The GHA (generalised hyperalgesia) may represent the 
involvement of a sensitized central nervous system, which requires an adapted pain management 
approach for this patient group [Rombaut et al., 2015].  
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Fatigue symptoms are heterogeneous in nature and can vary from mild to severe. However, 
patients often report fatigue symptoms as the most disabling complaint. In addition, neurologically 
oriented symptoms (proprioceptive deficits, central mediated hyperalgesia), psychological 
dysfunction (anxiety, depression) and systemic complaints (organ dysfunction, dysautonomia) are 
often highly prevalent in JHS/hEDS [Voermans et al., 2011, de Paepe et al., 2012]. 
 
 
Muscle strength, Proprioception and Balance 
Rombaut et al. [2012] demonstrated severely reduced quantitative muscle function and impairment 
in physical function in patients with JHS/hEDS compared to age- and sex-matched controls. The 
muscle weakness may be due to muscle dysfunction rather than reduced muscle mass. Whether 
muscle strength and endurance can be improved by appropriate exercise programs needs 
evaluation in further studies. Compared with healthy participants, individuals with JHS/hEDS 
showed significantly impaired balance, reflected by increased sway velocity, mediolateral and 
anteroposterior sway excursion, and sway area during modified Clinical Test of Sensory Interaction 
on Balance (mCTSIB) and the Tandem Stance test (TS). Gait velocity, step length, and stride 
length were significantly smaller during all walking conditions, and a significant dual-task-related 
decrement was found for gait velocity, step and stride length, and cadence in the JHS/hEDS 
subjects compared with the control group. Ninety-five percent of the patients fell during the past 
year, and some fear of falling was further measured [Rombaut et al., 2011]. DCD may persist into 
adulthood. In a case control study 56% of those with JHS/EDS-HT met the criteria for adult DCD 
[Clark et al., 2014]. Proprioception has been shown to be impaired in a number of studies [Smith et 
al., 2013].  
 
Extra-Articular Features 
Dysautonomia, defined as a term for various conditions in which the autonomic nervous system 
does not work correctly, provides a complex challenge for the multidisciplinary team. 
Dysautonomia consisting of cardiovascular dysfunction is found to be present in JHS/hEDS. 
Neuropathy, connective tissue laxity, and vasoactive medication are likely to play a role in its 
development [de Wandele et al., 2014]. Gastrointestinal symptoms are also commonly reported 
[Zarate et al., 2010], impact significantly on quality of life and are managed in a variety of ways. 
Specialist medical referral may be necessary. Constipation requires active treatment usually 
including dietary advice, however sustained use of laxatives is often required. Adult women with 
JHS/hEDS have an increased rate of incontinence. Both case-control and cross-sectional studies 
consistently report that 60-73.3% of adult women with JHS/hEDS have urinary incontinence, 
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compared with only 30-48.3% in non-affected women [Mastoroudes et al., 2013]. The increased 
rate seen in women with JHS/hEDS is present with various types of incontinence, including 
urgency incontinence, nocturnal enuresis and intercourse incontinence [Nijs et al., 2000]. Other 
symptoms of lower urinary tract dysfunction including nocturia (waking one or more times at night 
to void), urgency, bladder pain, urinary tract infections and voiding difficulties (poor stream, 
straining, incomplete bladder emptying, postmicturition dribble) have also been reported to be 
significantly more prevalent in women with JHS/hEDS [Mastoroudes et al., 2013]. No studies have 
yet investigated incontinence or other lower urinary tract symptoms in adult men with JHS/hEDS. 
 
Impaired bone health in adults with JHS/hEDS has been demonstrated by significant reductions in 
volumetric bone density measured at the distal radius site using peripheral quantitative computed 
tomography in comparison with age and gender matched peers [Nijs et al., 2000]. However, in 
contrast Carbone et al. [2000] found that after correction for height, weight and amount of physical 
activity, no significant differences between bone density measured by dual energy absorptiometry 
was found in adults with JHS/hEDS and controls. 
 
Activities and Participation 
Significant disability has been shown in patients with JHS/hEDS in ambulation (walking, running, 
stair climbing), activities of daily living (personal hygiene, self-care) and sports activities, 
influencing quality of life. The high number and severity of complaints in JHS/hEDS result in 
substantial care and treatment seeking. In a group of 78 adults with JHS/hEDS registered as 
patients in a rehabilitation medicine department, 92.4% were medication consumers, 70.9% had 
underwent several surgical interventions, and 51.9% had received physiotherapy treatment 
[Rombaut et al., 2011]. The main objective of rehabilitation is to reduce disability and to improve 
quality of life, however, evidence concerning effectiveness of treatment for reducing disability is 
limited, as are the actual factors related to disability. A recent meta-analysis showed that pain, 
fatigue and psychological distress had a significant impact on disability [Scheper et al., 2016]. 
 
Psychological Symptoms 
A systematic review has demonstrated that compared with their non-affected peers, adults with 
JHS/hEDS have greater risk of anxiety, depression and panic disorders [Smith et al., 2014]. A 
nationwide population – based cohort study showed a high incidence of psychiatric disorders 
including anxiety, depression, attention deficit hyperactivity disorder and autism spectrum disorder 
in the JHS/hEDS patient population [Cederlöf et al., 2016]. 
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PRINCIPLES OF MANAGEMENT OF INDIVIDUALS WITH JHS/EDS-HT IN CHILDHOOD, 
ADOLESCENCE AND ADULTHOOD  
In children and adults with JHS/hEDS with symptomatic joints or intestinal and systemic problems, 
differential diagnostics have to be performed to exclude other diseases or disorders that are 
characterized by GJH. In individuals with GJH, easy bruising and frequent fracturing, the presence 
of a collagen disease such as osteogenesis imperfecta or osteopenia due to vitamin D deficiency 
should be considered. When GJH and musculoskeletal complaints as well as a Marfanoid habitus 
is present, Marfan or Loeys-Dietz syndrome should be considered. Severe collagen diseases, such 
as the other types of EDS should be excluded. In case of progressive muscle weakness central of 
peripheral neurological conditions including myopathies should be ruled out. Additionally, 
rheumatology conditions should also be considered and ruled out.  
 
Kemp et al. [2010], performed the first prospective randomized controlled trial (RCT) in children 
comparing a 6-week generalized program, improving muscular strength and fitness, with a targeted 
program aimed at correcting motion control of symptomatic joints. It was demonstrated in 57 
children that significant improvements in both the children’s and parental pain scores were reached 
in both groups. A recent RCT study of children with JHS/hEDS and hypermobile knees found an 
increased effect on psychosocial/self-esteem in the group that performed knee exercises into the 
hypermobile range of motion (ROM) compared with the control group performing knee exercises 
into neutral ROM. Both groups improved knee strength and reduced knee pain [Pacey et al., 2013]. 
Evidence based guidelines suggest that children with flexible flat foot presenting with pain or 
impaired function, particularly in the presence of GJH, such as that commonly seen in children with 
JHS/hEDS, should use orthotics and/or sensible footwear [Evans et al., 2011]. Preliminary findings 
of a small RCT suggests that use of orthotics may improve the efficiency of gait of children with 
GJH and DCD [Morrison et al., 2013]. 
 
Only one RCT study of adults with JHS/hEDS has been performed, showing reduced knee pain 
and increased proprioception, in the group receiving exercises of proprioception, balance and 
plyometrics, compared with a matched control group receiving no exercises [Sahin et al., 2008].  
 
A number of cohort/uncontrolled clinical studies of JHS/hEDS in children and adults report positive 
effects of strength, core stability and endurance training in addition to education in pain 
management [Bathen et al., 2013], different intensity of resistive training alone [Moller et al., 2014; 
Ferrell,et al., 2004], and education in pain management alone [Rahman et al., 2014]; however, 
 12 
these reports need to be further evidenced with more rigorous research designs. Existing 
consensus based hospital and UK paediatric rheumatology guidelines may also offer helpful advice 
and treatment strategies to clinicians [The British Society for Pediatric and Adolescent 
Rheumatology, 2013; Cincinnati Children’s Hospital Medical Center, 2014]. Qualitative interviews 
with 28 families with children with JHS/hEDS (5-17 years) on prerequisites for the best adherence 
to exercise is reported to be parental motivation adapting family routines, making exercise a family 
activity and seeing the benefit [Birt et al., 2014]. On the other hand are factors for non-adherence 
to exercise for these children, lower levels of parental supervision, not understanding the 
treatment, not seeing the benefit and not having specific time to dedicate for doing exercises [Birt 
et al., 2014]. 
 
There is some evidence for that JHS/hEDS improves with exercise, but there is no convincing 
evidence for specific types of exercise or that exercise is better than control [Smith et al., 2013; 
Palmer et al., 2014]. Both reviews recommend that longer term, rigorous high-quality multi-centre 
RCT’s are warranted for children and adults with JHS/hEDS. 
 
Education, reassurance, manual therapy, tape, hydrotherapy and relaxation training are sometimes 
used by physical therapists [Lyell et al., 2015; Palmer et al., 2015; Rombaut et al., 2015; Billings et 
al., 2016] and clinical experts recommend these strategies [Russek et al., 2000; Simmonds and 
Keer, 2007; Keer and Simmonds 2011], based on clinical experience and some evidence from 
other patient groups. Currently there are no RCT’s or comparative trials to support the efficacy of 
these strategies in individuals with JHS/hEDS. Therapies should be individualized [Simmonds and 
Keer, 2007, 2008; Simmonds et al., 2016a] and applied carefully to avoid exacerbation of pain as 
peripheral and central sensitization is commonly observed [Rombaut et al., 2011]. Although Adib et 
al. [2005] refer to 25% of children using mobility aids in a selected population and splints are 
sometimes recommended, limited effect of these aids and splinting for hands/wrists in individuals 
with JHS/hEDS has been found [Smith et al., 2013].  
 
Cardiovascular, musculoskeletal and physical fitness training parameters should be encouraged in 
both children and adults according to the criteria of the National Strength and Conditioning 
Association (NSCA) and American College of Sports Medicine (ACSM) [Faigenbaum et al., 2009, 
2010; Garber et al., 2011]. In general, specialists recommend a carefully graduate exercise training 
prescription, underpinned by motor learning theory [Smith et al., 2014] to avoid injury and 
overtraining as this may lead to loss of confidence in the physical therapist. Pain, fatigue and fear 
of injury are commonly reported barriers to exercise [Simmonds et al., 2016b].  A graduated return 
 13 
to higher levels of sport or dance is recommended, and training loads should be observed to 
ensure adequate recovery. 
 
Patients with JHS/hEDS have numerous complaints and an impaired functional status that strongly 
determine their high rate of treatment consumption. The outcome of surgical and physical therapy 
treatment is largely disappointing, which illustrates the need for a stronger evidence base 
[Rombaut et al., 2011]. Education for health professionals [ Billings et al., 2015, Rombaut et al., 
2015, Terry et al., 2015, Lyell et al., 2016; Russek et al., 2016) is paramount in order to optimize 
physical therapy provision. A recent feasibility study of a 6 session package of treatment 
demonstrates future potential [Palmer et al., 2016] and further research is required to explore the 
specific therapeutic actions of physical therapy for managing JHS/hEDS [Palmer et al., 2016]. 
Recently, a meta-analysis revealed that for treatment of adults, a significant pain reduction was 
achieved by a variety of physical and cognitive approaches. Active modes of physical therapy are 
the recommended approach. However, the effectiveness on disability still needs to be established 
[Scheper et al., 2016].  
 
In cases where significant systemic signs and symptoms are observed and reported by individuals, 
such as cardiac dysautonomia, gastrointestinal, urinary and bladder dysfunction, referral to 
specialist medical teams is indicated. Readers are referred to care guidelines in these specialist 
areas. Physiotherapists play an important role in management through exercise prescription and 
patient education for many of these conditions. Relatively recent developed masterclass courses, 
papers and symposia provide clinicians with information on how to adapt and apply therapies 
[Simmonds and Keer, 2007; 2008; Simmonds et al., 2016]. 
 
CONCLUSION 
Children, adolescents and adults suffering from JHS/hEDS frequently present with complex 
symptoms and are therefore challenging for physical therapists to manage effectively. Based on 
the ICF, a literature overview has been presented for the assessment and management based on 
the best evidence available to help guiding clinicians. The current evidence-base for the physical 
therapy assessment and management of JHS/hEDS is limited in size and quality. 
 
In future directions longer term, rigorous multicenter randomized controlled trials are warranted to 
assess the clinical and cost-effectiveness of interventions for children and adults with JHS/hEDS. 
There is a need for further identification and validation of suitable outcome measures. Until further 
 14 
multicenter trials are conducted, clinical decision-making should be theoretically applied based, 
underpinned by the available evidence where available. In patients diagnosed with JHS/hEDS 
international consensus and combined efforts to identify patient risk profiles would create a better 
understanding of the pathological mechanisms with the possibility of optimizing health care for 
affected individuals.   
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Figure 1. Proposed ICF model for JHS in children by Pacey (2014), 
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